Protective effects of tanshinone I against cisplatin-induced nephrotoxicity in mice

Document Type : Short Communication


1 Department of Pharmacy, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang 443003, P.R. China

2 School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, P.R. China

3 Department of Nephrology, The First College of Clinical Medical Science, China Three Gorges University & Yichang Central People’s Hospital, Yichang 443003, P.R. China


Objective(s): Cisplatin (CDDP) is a highly effective chemotherapeutic agent, but its clinical application has been limited by nephrotoxicity. Tanshinone Ⅰ (T-I), a phenanthrenequinone compound extracted from the Chinese herb Danshen, has been used to improve circulation and treat cardiovascular diseases. The aim of this study was to investigate the protective effect of T-I on CDDP-induced nephrotoxicity in mice.
Materials and Methods: The BALB/c mouse models of nephrotoxicity were established by a single intraperitoneal injection of 20 mg/kg CDDP on the first day of the experiment. Three hours prior to CDDP administration, the mice were dosed with 10 mg/kg and 30 mg/kg T-I for 3 consecutive days intraperitoneally to explore nephroprotection of T-I.
Results: Treatment with T-I significantly reduced blood urea nitrogen and creatinine levels in serum observed in CDDP-administered mice, especially at a dose of 30 mg/kg. T-I at 30 mg/kg significantly decreased malondialdehyde levels and increased glutathione levels and the enzymatic activity of catalase in kidney tissue compared to CDDP. Additionally, T-I (30 mg/kg) significantly reversed the CDDP-decreased expression level of superoxide dismutase 2 protein in renal tissue. Histopathological evaluation of the kidneys further confirmed the protective effect of T-I. 
Conclusion: The findings of this study demonstrate that T-I can protect against CDDP-induced nephrotoxicity through suppression of oxidative stress. 


1. Holditch SJ, Brown CN, Lombardi AM, Nguyen KN, Edelstein CL. Recent advances in models, mechanisms, biomarkers, and interventions in cisplatin-induced acute kidney injury. Int J Mol Sci 2019; 20:3011-3035.
2. Barabas K, Milner R, Lurie D, Adin C. Cisplatin: A review of toxicities and therapeutic applications. Vet Comp Oncol 2008; 6:1-18.
3. Miller RP, Tadagavadi RK, Ramesh G, Reeves WB. Mechanisms of cisplatin nephrotoxicity. Toxins 2010; 2:2490-2518.
4. Manohar S, Leung N. Cisplatin nephrotoxicity: A review of the literature. J Nephrol 2018; 31:15-25.
5. Bazmandegan G, Amirteimoury M, Kaeidi A, Shamsizadeh A, Khademalhosseini M, Nematollahi MH, et al. Sumatriptan ameliorates renal injury induced by cisplatin in mice. Iran J Basic Med Sci 2019; 22:563-567.
6. Ray PD, Huang B-W, Tsuji Y. Reactive oxygen species (ROS) homeostasis and redox regulation in cellular signaling. Cell Signal 2012; 24:981-990.
7. Nazari Soltan Ahmad S, Rashtchizadeh N, Argani H, Roshangar L, Ghorbanihaghjo A, Sanajou D, et al. Tangeretin protects renal tubular epithelial cells against experimental cisplatin toxicity. Iran J Basic Med Sci 2019; 22:179-186.
8. Zhou S, Chen W, Su H, Zheng X. Protective properties of tanshinone I against oxidative DNA damage and cytotoxicity. Food Chem Toxicol 2013; 62:407-412.
9. Dai C, Liu Y, Dong Z. Tanshinone I alleviates motor and cognitive impairments via suppressing oxidative stress in the neonatal rats after hypoxic-ischemic brain damage. Mol Brain 2017; 10:52-62.
10. Tao S, Zheng Y, Lau A, Jaramillo MC, Chau BT, Lantz RC, et al. Tanshinone I activates the Nrf2-dependent anti-oxidant response and protects against As(III)-induced lung inflammation in vitro and in vivo. Anti-oxid Redox Signal 2013; 19:1647-1661.
11. Feng C, Xie X, Wu M, Li C, Gao M, Liu M, et al. Tanshinone I protects mice from aristolochic acid I-induced kidney injury by induction of CYP1A. Environ Toxicol Pharmacol 2013; 36:850-857.
12. Wang Y, Xi Y, Peng Y, Shen F, Deng Z, Zhang X, et al. Tanshinone I prevents cisplatin-induced cytotoxicity through Nrf2 activation in human renal proximal tubular epithelial cells. Lat Am J Pharm 2018; 37:2159-2166.
13. Kang L, Zhao H, Chen C, Zhang X, Xu M, Duan H. Sappanone A protects mice against cisplatin-induced kidney injury. Int Immunopharmacol 2016; 38:246-251.
14. Jing X, Wei X, Ren M, Wang L, Zhang X, Lou H. Neuroprotective effects of Tanshinone I against 6-OHDA-induced oxidative stress in cellular and mouse model of Parkinson’s disease through upregulating Nrf2. Neurochem Res 2016; 41:779-786.
15. Zhang W, Hou J, Yan X, Leng J, Li R, Zhang J, et al. Platycodon grandiflorum saponins ameliorate cisplatin-induced acute nephrotoxicity through the NF-kappaB-mediated inflammation and PI3K/Akt/apoptosis signaling pathways. Nutrients 2018; 10:1328.
16. Levi J, Jacobs C, Kalman SM, McTigue M, Weiner MW. Mechanism of cis-platinum nephrotoxicity: I. Effects of sulfhydryl groups in rat kidneys. J Pharmacol Exp Ther 1980; 213:545-550.
17. Bazmandegan G, Fatemi I, Kaeidi A, Khademalhosseini M, Fathinejad A, Amirteimoury M. Calcium dobesilate prevents cisplatin-induced nephrotoxicity by modulating oxidative and histopathological changes in mice. Naunyn Schmiedebergs Arch Pharmacol 2021; 394:515-521.
18. Chirino YI, Pedraza-Chaverri J. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Exp Toxicol Pathol 2009; 61:223-242.
19. Pabla N, Dong Z. Cisplatin nephrotoxicity: mechanisms and renoprotective strategies. Kidney Int 2008; 73:994-1007.
20. de Oliveira MR, Furstenau CR, de Souza ICC, da Costa Ferreira G. Tanshinone I attenuates the effects of a challenge with H2O2 on the functions of tricarboxylic acid cycle and respiratory chain in SH-SY5Y cells. Mol Neurobiol 2017; 54:7858-7868.
21. Ismail RS, El-Awady MS, Hassan MH. Pantoprazole abrogated cisplatin-induced nephrotoxicity in mice via suppression of inflammation, apoptosis, and oxidative stress. Naunyn Schmiedebergs Arch Pharmacol 2020; 393:1161-1171.
22. Furstenau CR, de Souza ICC, de Oliveira MR. Tanshinone I induces mitochondrial protection by a mechanism involving the Nrf2/GSH axis in the human neuroblastoma SH-SY5Y cells exposed to methylglyoxal. Neurotox Res 2019; 36:491-502.